Overall, these findings deepen our understanding of the molecular changes linked to high‐risk HPV infections and identify PI3K, MALAT1 and H19 as promising biomarkers and therapeutic targets for cervical cancer. This evidence concerns the gene MALAT1 and cervical carcinoma.